AbbVie
The LBA Automation Scientist II role supports pre-clinical bioanalytical programs in a fast-paced, non-regulated environment, focusing on the bioanalysis of animal samples dosed with large molecule therapeutics. The position involves designing and optimizing automation protocols for LBA workflows on Tecan and Hamilton liquid handlers to support PK, PD, TK, and ADA studies. This lab-based role requires strong expertise in bioanalytical assay design, data interpretation, and automation strategies for oncology, immunology, and neuroscience portfolios.
Headquarters
North Chicago, Illinois, United States
Company Size
10001+ employees
Founded
2013
AbbVie is a global, research-driven biopharmaceutical company that was spun off from Abbott Laboratories in 2013. It develops and commercializes specialty medicines across immunology, oncology, neuroscience, eye care and virology — with Humira historically its flagship product — and has broadened its portfolio through acquisitions (notably Allergan) and strategic collaborations. AbbVie emphasizes a robust R&D pipeline, targeted therapies, and global commercial and manufacturing capabilities. The company focuses on delivering long-term treatment options for complex, chronic and serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AbbVie.